跳至主要内容
临床试验/NL-OMON47569
NL-OMON47569已完成不适用

Vincristine-induced peripheral neuropathy in children with childhood cancer: comparing one-hour infusions with short-term infusions (the VINCA-study) - The VINCA-study

Vrije Universiteit Medisch Centrum0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 99(—)

入选标准

  • age between 2 and 19 years.
  • treated for cancer according to a treatment protocol which includes at least
  • 6 administrations of VCR of which 4 are administered within a maximum period
  • of maximum 6 weeks (these are acute lymphoblastic leukemia, nephroblastoma,
  • Hodgkin lymphoma, low-grade glioma, medulloblastoma and rhabdomyosarcoma)
  • diagnosed with a cancer diagnosis of which the incidence in the Netherlands
  • is of more than 5 newly diagnosed patients per year; within the Netherlands
  • written informed consent.;

排除标准

  • patient or parent refusal
  • history of peripheral neuropathy or other pre-existing or disease- related
  • sensory or motor neurologic conditions
  • pre-existing severe mental retardation;
  • having parents/ guardians who are unable to communicate in the Dutch

研究者

相似试验